Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients

被引：8

作者：

Moldovan, Diana ^{[1
]}

Kacso, Ina Maria ^{[1
]}

Rusu, Crina ^{[1
]}

Potra, Alina ^{[1
]}

Bondor, Cosmina Ioana ^{[2
]}

Moldovan, Ioan ^{[3
]}

Patiu, Ioan Mihai ^{[4
]}

Vladutiu, Dan ^{[1
]}

Caprioara, Mirela Gherman ^{[1
]}

机构：

[1] Univ Med & Pharm Iuliu Hatieganu, Dept Nephrol, Cluj Napoca, Romania

[2] Univ Med & Pharm Iuliu Hatieganu, Dept Stat, Cluj Napoca, Romania

[3] Emergency Mil Hosp, Cluj Napoca, Romania

[4] Nefromed Dialysis Ctr, Cluj Napoca, Romania

来源：

BIOMARKERS | 2015年 / 20卷 / 02期

关键词：

Cardiovascular disease; immunotoxicity; renal disease; CHRONIC KIDNEY-DISEASE; INTIMA-MEDIA THICKNESS; SERUM OSTEOPROTEGERIN; CARDIOVASCULAR EVENTS; FETUIN-A; ELEVATED OSTEOPROTEGERIN; CALCIFICATION INHIBITORS; PLASMA OSTEOPROTEGERIN; HEMODIALYSIS; ARTERY;

D O I：

10.3109/1354750X.2014.1000376

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aim: To assess the osteoprotegerin (OPG) relationship with cardiovascular complications in hemodialysis (HD) patients. Methods: The study included 87 HD patients. Clinical characteristics, ankle-arm index (AAI), OPG and mineral markers levels were recorded. Arterial intimal calcification (AIC) and arterial medial calcification (AMC) were registered. Results: OPG levels were increased in HD patients. Patients with AIC (p = 0.006)/ AMC (p = 0.01) had higher OPG levels. OPG did not have any relation with cardiovascular diseases. OPG correlated positively with age, increased HD vintage and inversely with albumin and AAI. OPG has not been a risk factor for VC or cardiovascular disease. Conclusion: OPG rising could be a reaction in defense to vascular aggression, because OPG was associated with VC, but not with vascular disease.

引用

页码：116 / 122

页数：7

共 50 条

[31] Permanent cardiac pacing in patients with end-stage renal disease undergoing dialysis
Wang, I-Kuan
Lin, Kuo-Hung
Lin, Shih-Yi
Lin, Cheng-Li
Chang, Chiz-Tzung
Yen, Tzung-Hai
Sung, Fung-Chang
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (12) : 2115 - 2122
[32] Aortic Arch Calcification and Clinical Outcome in Patients with End-Stage Renal Disease
Nitta, Kosaku
Ogawa, Tetsuya
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 223 (02) : 79 - 84
[33] Management of hepatitis C in patients with end-stage renal disease
Berenguer M.
Aguilera V.
Current Hepatitis Reports, 2010, 9 (1) : 38 - 46
[34] Serum Levels of Omentin in End-Stage Renal Disease Patients
Alcelik, Aytekin
Tosun, Mehmet
Ozlu, Mehmet Fatih
Eroglu, Mustafa
Aktas, Gulali
Kemahli, Eray
Savli, Haluk
Yazici, Mehmet
KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 35 (06) : 511 - 516
[35] Dialysis Therapies in Older Patients with End-Stage Renal Disease
Malavade, Tuschar
Sokwala, Ahmed
Jassal, Sarbjit Vanita
CLINICS IN GERIATRIC MEDICINE, 2013, 29 (03) : 625 - +
[36] Cardiac surgery in patients with end-stage renal disease on dialysis
Back, Caroline
Hornum, Mads
Moller, Christian Joost Holdflod
Olsen, Peter Skov
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2017, 51 (06) : 334 - 338
[37] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
Naiman, Natalie
Cheung, Alfred K.
Goldfarb-Rumyantzev, Alexander S.
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
[38] A road map for patients with imminent end-stage renal disease
Burkhalter, Felix
Steiger, Juerg
Dickenmann, Michael
SWISS MEDICAL WEEKLY, 2012, 142
[39] Mineralocorticoid Receptor Antagonists in Patients With End-Stage Renal Disease on Chronic Hemodialysis
Pitt, Bertram
Rossignol, Patrick
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) : 537 - 538
[40] Elevated homocysteine levels in patients with end-stage renal disease
Nair, AP
Nemirovsky, D
Kim, M
Geer, EB
Farkouh, ME
Winston, J
Halperin, JL
Robbins, MJ
MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (06): : 365 - 373

← 1 2 3 4 5 →